This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fontaine, M. C.
Right arrow Articles by Willson, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fontaine, M. C.
Right arrow Articles by Willson, P. J.

 Previous Article  |  Next Article 

Infection and Immunity, February 2004, p. 774-781, Vol. 72, No. 2
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.2.774-781.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Investigation of a Novel DNase of Streptococcus suis Serotype 2{dagger}

Michael C. Fontaine,{ddagger} Jose Perez-Casal, and Philip J. Willson*

Vaccine & Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan S7N 5E3, Canada

Received 1 May 2003/ Returned for modification 28 July 2003/ Accepted 23 October 2003

A secreted nuclease, SsnA, was identified in the virulent Streptococcus suis isolate SX332 and subsequently in each of the type strains of capsular serotypes 1 through 9. Screening of 258 porcine clinical isolates from surface (nasal mucosa or palatine tonsil) or internal (joint, brain or other internal organ) locations revealed a significant relationship (P < 0.001) between expression of nuclease and isolation from an internal site. A 3,126-bp gene, ssnA, was identified from a phenotypically nuclease-negative pGh9:ISS1 insertion mutant, and analysis of the predicted SsnA sequence revealed a 35-amino-acid (aa) secretion signal sequence, a 22-aa DNA-binding domain, and a typical gram-positive cell wall sorting motif. A requirement of Ca2+ and Mg2+ for SsnA activity was determined, and the substrate specificity was found to be for single- and double-stranded linear DNA. Reverse transcription-PCR experiments revealed that ssnA is expressed throughout all stages of S. suis growth, and Western blots with porcine anti-S. suis immune sera against a recombinant, truncated SsnA derivative (rSsnA{Delta}) confirmed that SsnA is expressed in vivo. Furthermore, anti-rSsnA{Delta} antibodies were sufficient to neutralize SsnA activity. Analyses of subcellular fractions of SX332 and derived mutants, on DNA-containing polyacrylamide gels and by Western blotting, suggest that SsnA is cell wall located.


* Corresponding author. Mailing address: Vaccine & Infectious Disease Organization, 120 Veterinary Rd., Saskatoon, Saskatchewan, S7N 5E3, Canada. Phone: (306) 966-7480. Fax: (306) 966-7478. E-mail: Willson{at}sask.usask.ca.

{dagger} Published as number 328 in the Vaccine & Infectious Disease Organization journal series.

Editor: V. J. DiRita

{ddagger} Present address: Moredun Research Institute, Penicuik EH26 0PZ, Scotland, United Kingdom.


Infection and Immunity, February 2004, p. 774-781, Vol. 72, No. 2
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.2.774-781.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Aranda, J., Garrido, M. E., Fittipaldi, N., Cortes, P., Llagostera, M., Gottschalk, M., Barbe, J. (2009). Protective capacities of cell surface-associated proteins of Streptococcus suis mutants deficient in divalent cation-uptake regulators. Microbiology 155: 1580-1587 [Abstract] [Full Text]  
  • Aranda, J., Garrido, M. E., Cortes, P., Llagostera, M., Barbe, J. (2008). Analysis of the Protective Capacity of Three Streptococcus suis Proteins Induced under Divalent-Cation-Limited Conditions. Infect. Immun. 76: 1590-1598 [Abstract] [Full Text]